|

Tislelizumab, Cisplatin, Gemcitabine and Vitamin B3 Clinical Trials

1 actively recruiting trial

Also known as: Cisplatin, Gemcitabine, Nicotinic Acid Tablets, Tislelizumab

Pipeline

Phase 1: 1

Top Sponsors

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1

Indications

  • Bladder (Urothelial, Transitional Cell) Cancer1
  • Cancer1

Other1 trial

Clinical Trial on the Protective Role of Vitamin B3 in Enhancing Immunotherapy for Bladder Cancer Patients
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.